Simková R, Kazdová L, Karasová L, Simek S, Pelikánová T
Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, the Czech Republic.
Diabet Med. 2004 Sep;21(9):968-75. doi: 10.1111/j.1464-5491.2004.01270.x.
The aim of this study was to evaluate the effect of acutely induced hyperglycaemia on renal sodium handling and to explore the role of the bradykinin-nitric oxide-cGMP signalling pathway.
We compared 20 Type 1 diabetic (DM1) patients without microalbuminuria with 15 weight-, age-, and sex-matched healthy controls (C). Clearances of para-aminohippuric acid (CPAH), inulin (Cin), lithium, sodium, and urinary nitrite/nitrate (NOx), cGMP and bradykinin excretion rates were measured in two 90-min periods: a glycaemic clamp-induced euglycaemia (5 mmol/l-period I) and hyperglycaemia (12 mmol/l-period II) (Study 1) and during time-controlled euglycaemia (5 mmol/l-period I and 5 mmol/l-period II) to avoid the effects of time and volume load (Study 2).
Cin and CPAH were not significantly different during euglycaemia (period I of Study 1) in DM1 and controls, whereas fractional excretion of sodium was decreased in DM1 (1.84 +/- 0.75 vs. 2.36 +/- 0.67%; P < 0.05) due to an increase in fractional distal tubular reabsorption of sodium (94.01 +/- 1.94 vs. 92.24 +/- 2.47%; P < 0.05). A comparison of changes during Study 1 and Study 2 revealed acute hyperglycaemia did not change renal haemodynamics significantly, while fractional distal tubular reabsorption of sodium increased (DM1: P < 0.05; C: P < 0.01) and fractional excretion of sodium decreased (P < 0.01) in both groups. The urinary excretion rates of NOx were comparable during euglycaemia in DM1 and C. While in C, they significantly increased during Study 1 (period I: 382 +/- 217 vs. period II: 515 +/- 254 nmol/min; P < 0.01) and Study 2 (period I: 202.9 +/- 176.8 vs. period II: 297.2 +/- 267.5 nmol/min; P < 0.05) as a consequence of the water load, no changes were found in DM1. The urinary excretion of bradykinin was lower in DM1 compared with C (0.84 +/- 0.68 vs. 1.20 +/- 0.85 micro g/min; P < 0.01) during euglycaemia; it was not affected by hyperglycaemia. There were no significant differences between DM1 and C and in cGMP urinary excretion rates following hyperglycaemia.
This study demonstrates that DM1 without renal haemodynamic alterations is associated with impaired renal sodium handling. Moreover, we did not find a relationship between the renal excretion rates of vasoactive mediators and sodium handling due to hyperglycaemia.
本研究旨在评估急性诱导的高血糖对肾脏钠处理的影响,并探讨缓激肽-一氧化氮-cGMP信号通路的作用。
我们将20例无微量白蛋白尿的1型糖尿病(DM1)患者与15例体重、年龄和性别匹配的健康对照者(C)进行比较。在两个90分钟时间段内测量对氨基马尿酸清除率(CPAH)、菊粉清除率(Cin)、锂、钠以及尿亚硝酸盐/硝酸盐(NOx)、cGMP和缓激肽排泄率:一个是血糖钳夹诱导的正常血糖期(5 mmol/L - 第一阶段)和高血糖期(12 mmol/L - 第二阶段)(研究1),以及在时间控制的正常血糖期(5 mmol/L - 第一阶段和5 mmol/L - 第二阶段)以避免时间和容量负荷的影响(研究2)。
在研究1的正常血糖期(第一阶段),DM1患者和对照组的Cin和CPAH无显著差异,而DM1患者的钠分数排泄降低(1.84±0.75%对2.36±0.67%;P<0.05),原因是远曲小管钠分数重吸收增加(94.01±1.94%对92.24±2.47%;P<0.05)。研究1和研究2中变化的比较显示,急性高血糖并未显著改变肾脏血流动力学,而两组中远曲小管钠分数重吸收均增加(DM1:P<0.05;C:P<0.01),钠分数排泄均降低(P<0.01)。DM1患者和对照组在正常血糖期的NOx尿排泄率相当。在对照组中,由于水负荷,它们在研究1(第一阶段:382±217对第二阶段:515±254 nmol/min;P<0.01)和研究2(第一阶段:202.9±176.8对第二阶段:297.2±267.5 nmol/min;P<0.05)中显著增加,而DM1患者未发现变化。在正常血糖期,DM1患者的缓激肽尿排泄低于对照组(0.84±0.68对1.20±0.85 μg/min;P<0.01);它不受高血糖影响。高血糖后DM1患者和对照组以及cGMP尿排泄率之间无显著差异。
本研究表明,无肾脏血流动力学改变的DM1患者存在肾脏钠处理受损。此外,我们未发现高血糖导致的血管活性介质肾排泄率与钠处理之间存在关联。